[CAS NO. 1210344-57-2]  Ertugliflozin

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1210344-57-2]

Store
Catalog
SLK-S5413
Brand
Selleck
CAS
1210344-57-2

DESCRIPTION [1210344-57-2]

Overview

MDLMFCD21609259
Molecular Weight436.88
Molecular FormulaC22H25ClO7
SMILESO[C@H]1[C@@]2(O[C@@](CO)(CO2)[C@@H](O)[C@@H]1O)C3=CC(CC4=CC=C(OCC)C=C4)=C(Cl)C=C3

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.2890 mL11.4448 mL22.8896 mL
5 mM0.4578 mL2.2890 mL4.5779 mL
10 mM0.2289 mL1.1445 mL2.2890 mL
50 mM0.0458 mL0.2289 mL0.4578 mL

Description

Ertugliflozin (MK-8835, PF-04971729) is a potent and selective inhibitor with IC50 values of 0.877 nM for h-SGLT2 and 1000-fold higher for h-SGLT1.

Targets

hSGLT2 [1]
(Cell-free assay)
0.877 nM

In vitro

Ertugliflozin (it is claimed) has a 2000-fold increase in selectivity for human SGLT2 over SGLT1 (IC50: SGLT2 = 0.877 nM vs SGLT1 = 1960 nM) in vitro.

In vivo

Ertugliflozin is rapidly absorbed in preclinical species after oral administration, and it is characterized by low clearance (excreted in the urine in preclinical species) and a moderate steady-state distribution volume. There is low potential for pharmacokinetic interaction of ertugliflozin. Ertugliflozin is well absorbed in humans and eliminated largely via glucuronidation. Ertugliflozin improved glycemic control, body weight and blood pressure in patients with T2DM suboptimally controlled by metformin, and is well-tolerated.


Synonyms

β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-
1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-β-L-idopyranose
Ertugliflozin
PF 04971729-00
PF 04971729
MK 8835